A Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients With Advanced Cancer

Clinical trial NCT05659732 · RECRUITING

Trial details

NCT number: NCT05659732
Sponsor: PharmaEngine
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Lymphoma, Mantle-Cell

Start date: 2023-07-17
Primary completion: 2026-12-31
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.